Data / Research funding / Microbiome
Microbiome: 3,431 NIH awards ($7.1B) to 407 organizations
3,431 NIH awards ($7.1B) in the NIH spending category Microbiome, to 407 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 3,431 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity | NIH | National Cancer Institute | 2021 to 2025 | $2,960,824,321 | August 31, 2025 | August 30, 2026 | BRISCOE, LYNN | reporter.nih.gov |
| The Long Life Family Study | NIH | National Institute on Aging | 2021 to 2025 | $60,108,132 | August 15, 2019 | June 30, 2030 | PROVINCE, MICHAEL A. | reporter.nih.gov |
| Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,858,092 | April 12, 2021 | March 31, 2028 | JACKSON, DANIEL J | reporter.nih.gov |
| IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $32,128,916 | February 1, 2025 | January 31, 2026 | MILLIN, CHRISTINA | reporter.nih.gov |
| Case Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,812,474 | August 1, 1997 | March 31, 2030 | SCHWARTZ, GARY K | reporter.nih.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,224,161 | April 9, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| Environmental triggers of early-onset colorectal cancer: interactions between microplastics and pks+ E coli in early-life gut colonization | NIH | National Cancer Institute | 2021 to 2025 | $22,669,275 | August 1, 1997 | July 31, 2026 | TUVESON, DAVID A | reporter.nih.gov |
| Partnerships for Biomedical Research in Arkansas | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,309,096 | September 30, 2001 | April 30, 2026 | CORNETT, LAWRENCE E | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,023,937 | April 1, 2019 | September 30, 2026 | SHARMA, ANJALI | reporter.nih.gov |
| Alzheimer's Gut Microbiome Project | NIH | National Institute on Aging | 2021 to 2023 | $20,743,566 | September 15, 2019 | August 31, 2025 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Reversing Immune Dysfunction for HIV-1 Eradication | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $20,001,273 | August 16, 2021 | October 31, 2026 | CHANDA, SUMIT K | reporter.nih.gov |
| South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,943,827 | September 30, 2001 | August 31, 2026 | GOLDSMITH, EDIE C | reporter.nih.gov |
| A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $19,147,537 | September 21, 2016 | May 31, 2030 | KARAGAS, MARGARET RITA | reporter.nih.gov |
| Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $17,176,139 | September 10, 2021 | July 31, 2026 | TREMOULET, ADRIANA H | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,678,563 | April 1, 2019 | September 30, 2026 | FRENCH, AUDREY | reporter.nih.gov |
| Life Course Cancer Epidemiology Cohort in Women | NIH | National Cancer Institute | 2021 to 2025 | $15,280,631 | June 1, 2013 | August 31, 2028 | ELIASSEN, A. HEATHER | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $14,260,643 | September 21, 2016 | May 31, 2025 | KARAGAS, MARGARET RITA | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,773,513 | January 17, 2018 | December 31, 2027 | WUNDERINK, RICHARD G | reporter.nih.gov |
| Functional Microbiomics, Inflammation and Pathogenicity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,492,994 | March 1, 2018 | February 29, 2028 | LAMONT, RICHARD J | reporter.nih.gov |
| Trans-omics Integration of Multi-omics Studies for Osteoporosis | NIH | National Institute on Aging | 2021 to 2025 | $12,202,183 | September 15, 2017 | June 30, 2027 | DENG, HONG-WEN | reporter.nih.gov |
| Early Life Adversity, Biological Embedding, and Risk for Developmental Precursors of Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $11,595,410 | May 22, 2018 | May 31, 2028 | LUBY, JOAN L. | reporter.nih.gov |
| Kynurenine accumulation drives loss of muscle and bone function with aging | NIH | National Institute on Aging | 2021 to 2025 | $11,563,609 | May 1, 2011 | May 31, 2027 | ISALES, CARLOS M. | reporter.nih.gov |
| California Partnership for Personalized Nutrition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $11,224,088 | December 10, 2021 | November 30, 2026 | ADAMS, SEAN HARRISON | reporter.nih.gov |
| The DUST Center: Hazardous Dust in Drylands - Exposure, Health Impacts, and Mitigation | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $11,160,526 | April 1, 1997 | January 31, 2030 | DING, XINXIN | reporter.nih.gov |
| The UCSD Microbiome and Metagenomics Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $10,609,774 | December 23, 2021 | November 30, 2026 | GILBERT, JACK ANTHONY | reporter.nih.gov |
| Nutrition Precision Health for All of Us (Chicago Center) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $10,228,129 | December 10, 2021 | November 30, 2026 | VAN HORN, LINDA VERNER | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| Tissue destruction and healing in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,512,977 | September 15, 2022 | July 31, 2027 | JABRI, BANA | reporter.nih.gov |
| Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study | NIH | National Cancer Institute | 2021 to 2025 | $9,251,154 | September 19, 2016 | August 31, 2026 | ULRICH, CORNELIA M | reporter.nih.gov |
| The Mutant Mouse Resource and Research Center at the University of Missouri | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,888,200 | May 1, 2000 | February 28, 2030 | AMOS-LANDGRAF, JAMES | reporter.nih.gov |
| Statistical Methods for Integrative Genomics in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $8,721,062 | July 1, 2016 | August 31, 2027 | GAUDERMAN, WILLIAM JAMES | reporter.nih.gov |
| Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $8,657,651 | August 5, 2014 | May 31, 2025 | ZEMPLENI, JANOS | reporter.nih.gov |
| Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,561,222 | September 10, 2021 | August 31, 2026 | FREIBERG, MATTHEW S | reporter.nih.gov |
| Southern Community Cohort Study | NIH | National Cancer Institute | 2021 to 2025 | $8,346,621 | July 21, 2016 | June 30, 2027 | ZHENG, WEI | reporter.nih.gov |
| Human Biomimetics for Mucosal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,059,968 | March 15, 2015 | May 31, 2027 | ESTES, MARY KOLB | reporter.nih.gov |
| DartCF: The Dartmouth Cystic Fibrosis Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,832,026 | July 1, 2018 | August 31, 2030 | MADDEN, DEAN R | reporter.nih.gov |
| Microbial Chemical Sensing and Host Responses | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $7,729,035 | April 1, 2021 | June 30, 2026 | CRAWFORD, JASON MICHAEL | reporter.nih.gov |
| Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | NIH | National Cancer Institute | 2022 to 2025 | $7,696,898 | September 20, 2022 | August 31, 2027 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| Small RNAs as Novel Modulators of Microbe-Host Interactions | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $7,525,895 | September 1, 2021 | April 30, 2027 | GITAI, ZEMER | reporter.nih.gov |
| Interactions Between the Microbiome, Immunity and Respiratory Health in Traditional Agrarian and Suburban children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,471,626 | February 1, 2013 | February 29, 2028 | GERN, JAMES E. | reporter.nih.gov |
| The Louisiana Clinical Center of Nutrition for Precision Health (LA-NPH) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $7,341,823 | December 10, 2021 | November 30, 2026 | RAVUSSIN, ERIC | reporter.nih.gov |
| Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $7,269,328 | March 15, 2023 | February 29, 2028 | DULAI, PARAMBIR SINGH | reporter.nih.gov |
| Integrative Multidisciplinary Discovery Platform to Unlock Marine Natural Products Therapeutic Opportunities | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $7,069,063 | August 1, 2022 | July 31, 2027 | LUESCH, HENDRIK | reporter.nih.gov |
| The oral environment in food allergy development (ONEIDA) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $6,732,986 | August 1, 2025 | June 30, 2029 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| A Foundation for the Oral Microbiome and Metagenome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $6,653,092 | April 1, 2006 | March 31, 2027 | MARK WELCH, JESSICA LEIGH | reporter.nih.gov |
| Integrated Epithelial and Muscosal Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,598,874 | September 1, 1997 | June 16, 2026 | LENCER, WAYNE I | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,503,998 | August 14, 2020 | May 31, 2027 | NADEAU, KARI C. | reporter.nih.gov |
| Mechanisms of Fecal Microbiota Transplant Protection from Recurrent C. difficile | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,326,957 | July 24, 2020 | June 30, 2029 | PETRI, WILLIAM A | reporter.nih.gov |
| Prenatal Exposures and Child Health Outcomes: A Statewide Study | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $6,156,799 | September 21, 2016 | August 31, 2023 | KERVER, JEAN MARIE | reporter.nih.gov |
| Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,122,586 | September 1, 2019 | May 31, 2025 | CHANG, EUGENE B | reporter.nih.gov |
| A universal pipeline for functional characterization of the human microbiota at a massive scale | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $6,002,443 | April 1, 2020 | March 31, 2026 | BUIE, CULLEN RICHARD | reporter.nih.gov |
| Genetic Control of Metabolic Flux in Response to Diet | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $5,939,998 | September 17, 2020 | June 30, 2026 | ATTIE, ALAN D | reporter.nih.gov |
| Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $5,896,816 | August 15, 2022 | May 31, 2027 | KANTHASAMY, ANUMANTHA GOUNDER | reporter.nih.gov |
| High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials | NIH | National Cancer Institute | 2023 to 2025 | $5,867,691 | September 30, 2017 | June 30, 2028 | GNJATIC, SACHA | reporter.nih.gov |
| Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,810,225 | September 19, 2013 | June 30, 2025 | SARTOR, RYAN B | reporter.nih.gov |
| Overcoming resistance to anti-PD1 immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $5,629,363 | December 7, 2016 | August 31, 2030 | GAJEWSKI, THOMAS F | reporter.nih.gov |
| Mutographs differentiating the inheritance and temporal onset of multiple myeloma | NIH | National Cancer Institute | 2021 to 2025 | $5,575,548 | August 11, 2021 | July 31, 2026 | MORGAN, GARETH JOHN | reporter.nih.gov |
| Cervical, Anal & Oral HPV Persistence/Adolescent Girls | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,549,203 | May 15, 2007 | January 31, 2028 | DIAZ, ANGELA | reporter.nih.gov |
| Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial | NIH | National Cancer Institute | 2021 to 2025 | $5,478,236 | September 22, 2021 | August 31, 2026 | LE MARCHAND, LOIC | reporter.nih.gov |
| Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $5,430,840 | April 12, 2019 | March 31, 2025 | LUETKEMEYER, ANNE FREY | reporter.nih.gov |
| Determinants of inception of inflammation in inflammatory bowel diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,397,834 | August 24, 2021 | May 31, 2027 | ANANTHAKRISHNAN, ASHWIN N | reporter.nih.gov |
| Novel polymeric materials with improved durability in the oral environment: tailoring responses to host and bacterial enzymes with anti-proteolytic and ecology-based antimicrobial approaches. | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $5,397,226 | September 1, 2019 | June 30, 2027 | PFEIFER, CARMEM S. | reporter.nih.gov |
| Gut Microbiome and Individual Differences in Lumbosacral Radicular Pain | NIH | National Center for Complementary & Integrative Health | 2025 | $5,318,433 | August 15, 2025 | July 31, 2029 | SHEN, SHIQIAN | reporter.nih.gov |
| Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $5,260,253 | September 21, 2016 | August 31, 2024 | WEISS, SCOTT T | reporter.nih.gov |
| Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,235,383 | September 18, 2019 | June 30, 2025 | WANG, DAVID | reporter.nih.gov |
| Skin microbes and development of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $5,176,858 | September 5, 2025 | August 31, 2029 | GALLO, RICHARD L | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Sialic acid analogs against multidrug-resistant gonorrhea | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,099,184 | April 20, 2021 | March 31, 2027 | RAM, SANJAY | reporter.nih.gov |
| Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,032,505 | September 21, 2024 | July 31, 2029 | JENQ, ROBERT | reporter.nih.gov |
| Reversing Immune Dysfunction for HIV-1 Eradication | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $5,001,807 | August 16, 2021 | October 31, 2021 | CHANDA, SUMIT K | reporter.nih.gov |
| Determinants of follicular helper T cell expansion in lupus | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,994,422 | July 8, 2020 | July 31, 2029 | MOREL, LAURENCE | reporter.nih.gov |
| Bacteriophage-based approach for managing Shigella infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,946,719 | May 5, 2020 | April 30, 2026 | SULAKVELIDZE, ALEXANDER | reporter.nih.gov |
| Advancing studies of polymicrobial diseases via streptococcal genetics | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,926,717 | September 1, 2018 | June 30, 2027 | MERRITT, JUSTIN | reporter.nih.gov |
| Microbial Programming of T-cell Migration from Gut to Brain | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,908,988 | July 14, 2025 | June 30, 2029 | WANG, ANDREW | reporter.nih.gov |
| Precision Prevention Research Program | NIH | National Cancer Institute | 2021 to 2025 | $4,849,798 | September 1, 2020 | August 31, 2027 | CHAN, ANDREW T | reporter.nih.gov |
| Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,809,096 | April 15, 2020 | March 31, 2026 | DORSEY, MATTHEW G | reporter.nih.gov |
| Algorithms and Software for the Assembly of Metagenomic Data | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,774,331 | March 21, 2013 | August 31, 2029 | POP, MIHAI | reporter.nih.gov |
| Susceptibility Patterns for Grade C Periodontitis in Young Individuals | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $4,773,268 | September 22, 2022 | August 31, 2027 | SHADDOX, LUCIANA MACCHION | reporter.nih.gov |
| The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory | NIH | National Institute on Aging | 2024 to 2025 | $4,768,289 | August 15, 2024 | July 31, 2029 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Development and Support of the Pathway Tools Software | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,665,041 | May 12, 2021 | April 30, 2026 | KARP, PETER D | reporter.nih.gov |
| Defining Drivers of HPV-associated Carcinogenesis | NIH | National Cancer Institute | 2021 to 2025 | $4,601,591 | August 1, 2017 | July 31, 2031 | LAMBERT, PAUL F. | reporter.nih.gov |
| Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy | NIH | National Cancer Institute | 2021 to 2025 | $4,541,273 | September 17, 2019 | August 31, 2026 | TING, JENNY P | reporter.nih.gov |
| Povidone Iodine Efficacy Study (PIES) | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $4,268,923 | May 1, 2022 | April 30, 2027 | KOPYCKA-KEDZIERAWSKI, DOROTA T. | reporter.nih.gov |
| Programmable benchtop bioreactors for scalable eco-evolutionary dynamics of the human microbiome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,135,886 | June 10, 2022 | May 31, 2027 | KHALIL, AHMAD SAMIR | reporter.nih.gov |
| High Resolution Characterization of Bacterial Epigenomes and Microbiome | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,119,232 | February 1, 2021 | January 31, 2026 | FANG, GANG | reporter.nih.gov |
| The small intestinal microbiota in undernourished women and undernourished children in Bangladesh: identifying causal mechanisms and therapeutic targets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,099,868 | September 21, 2021 | May 31, 2026 | GORDON, JEFFREY I | reporter.nih.gov |
| Social Isolation and Discrimination as Stressors Influencing Brain-Gut Microbiome Alterations among Filipino and Mexican American | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $4,084,828 | April 1, 2021 | December 31, 2026 | CHURCH, ARPANA | reporter.nih.gov |
| Fragile Families: The Third Generation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $4,015,455 | August 19, 2021 | April 30, 2027 | TEITLER, JULIEN O | reporter.nih.gov |
| Impact of chronic alcohol consumption on the functional and epigenetic landscapes of monocytes and their progenitors | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,998,523 | September 1, 2020 | August 31, 2029 | MESSAOUDI, ILHEM | reporter.nih.gov |
| Is Obesity an Infectious Disease?: Gut bacterial and fungal translocation as an underappreciated driver of visceral adipose expansion. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,971,090 | September 30, 2021 | June 30, 2026 | DEVKOTA, SUZANNE | reporter.nih.gov |
| A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health | NIH | National Institute on Aging | 2021 to 2025 | $3,954,825 | September 30, 2021 | June 30, 2027 | NOBLE, JAMES MCCALLUM | reporter.nih.gov |
| Gut barrier function in Alzheimer’s disease | NIH | National Institute on Aging | 2021 to 2025 | $3,945,245 | February 15, 2021 | January 31, 2026 | BENDLIN, BARBARA BRIGITTA | reporter.nih.gov |
| Food Timing to Mitigate Adverse Consequences of Night Work | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,943,217 | July 1, 2021 | June 30, 2027 | SCHEER, FRANK A | reporter.nih.gov |
| Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,935,193 | February 1, 2022 | January 31, 2027 | XAVIER, RAMNIK J | reporter.nih.gov |
| The Center for High Content Functional Annotation of Natural Products | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $3,906,784 | September 1, 2015 | June 30, 2025 | MACMILLAN, JOHN B | reporter.nih.gov |
| ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,900,002 | March 21, 2022 | December 31, 2026 | RITCHLIN, CHRISTOPHER TREVOR | reporter.nih.gov |
| Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,899,337 | June 1, 2021 | May 31, 2027 | SHIVAKOTI, RUPAK | reporter.nih.gov |
| Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,895,544 | September 9, 2021 | July 31, 2027 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| Dietary and synbiotic strategy to limit gut microbiome dysbiosis and protect against Clostridioides difficile infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,880,251 | April 23, 2021 | March 31, 2027 | LOZUPONE, CATHERINE | reporter.nih.gov |
| Autoimmune Drivers and Protectors Team Science (ADAPTS) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,860,822 | March 1, 2023 | February 29, 2028 | JAMES, JUDITH A | reporter.nih.gov |
| Mechanisms and pathophysiologic impact of claudin-2 modulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,845,865 | September 29, 2001 | June 30, 2028 | TURNER, JERROLD R. | reporter.nih.gov |
| Population Genomic Analysis of Gut Microbial Colonization in Premature Infants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,825,244 | July 15, 2011 | June 30, 2026 | BANFIELD, JILLIAN | reporter.nih.gov |
| Impact of early-life perturbations on pediatric microbiome maturation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,815,792 | June 8, 2021 | June 23, 2026 | DANTAS, GAUTAM | reporter.nih.gov |
| The Gut Microbiome and Personalized Mediterranean Diet Interventions for Cardiometabolic Disease Prevention | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,777,491 | September 23, 2021 | June 30, 2027 | WANG, DONG | reporter.nih.gov |
| Commensal microbiome impact on CD4 T cell lymphopenia in HIV-1 infection | NIH | National Institute on Aging | 2022 to 2025 | $3,776,712 | September 15, 2022 | May 31, 2027 | YOUNES, SOUHEIL ANTOINE | reporter.nih.gov |
| Preventing dental caries through targeted treatment of acid-producing bacteria | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,746,349 | September 1, 2021 | August 31, 2026 | SUN, JIRUN | reporter.nih.gov |
| Omics Data Generation Center (ODGC) for the Acute to Chronic Pain Signatures (A2CPS) Program | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,741,527 | September 1, 2019 | July 31, 2027 | LAURENT, LOUISE CHANG | reporter.nih.gov |
| Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,738,057 | March 4, 2019 | April 30, 2029 | SCOTT, PHILLIP | reporter.nih.gov |
| Understanding Oral Diseases in Cystic Fibrosis to Develop Tailored Preventive Dental Interventions | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,727,321 | April 13, 2021 | March 31, 2027 | KIM, AMY S | reporter.nih.gov |
| Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes | NIH | National Cancer Institute | 2021 to 2025 | $3,678,371 | September 7, 2021 | August 31, 2026 | YUAN, JIAN-MIN | reporter.nih.gov |
| Role of the Intestinal Microbiota in ALS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,664,593 | January 15, 2021 | December 31, 2025 | WEINER, HOWARD L | reporter.nih.gov |
| Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER | NIH | National Institute of Mental Health | 2021 to 2025 | $3,655,824 | December 8, 2020 | October 31, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,646,054 | April 15, 2021 | March 31, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,635,308 | August 17, 2021 | July 31, 2027 | MARGOLIS, DAVID JOEL | reporter.nih.gov |
| Reserve against Disability in Early Multiple Sclerosis (RADIEMS) Longitudinal Cohort Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,629,278 | July 11, 2016 | July 31, 2026 | SUMOWSKI, JAMES FRANCIS | reporter.nih.gov |
| Biofilm Elimination and Caries Prevention using Multifunctional Nanocatalysts | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,608,276 | December 9, 2016 | August 31, 2027 | KOO, HYUN | reporter.nih.gov |
| A large scale investigation of the vaginal metagenome and metabolome and their role in spontaneous preterm birth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,589,881 | August 3, 2021 | July 31, 2027 | KOREM, TAL | reporter.nih.gov |
| Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,585,446 | July 1, 2010 | June 30, 2027 | NAKAGAWA, MAYUMI | reporter.nih.gov |
| Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,584,464 | June 15, 2022 | March 31, 2027 | ELLIS, RONALD J. | reporter.nih.gov |
| A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,558,479 | August 16, 2022 | July 31, 2028 | HEBERT, JAMES R | reporter.nih.gov |
| Targeting the Intestinal Mucosa and Microbiome to Prevent Neonatal Late-onset Sepsis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,526,115 | August 1, 2021 | July 31, 2027 | WEAVER, CASEY T | reporter.nih.gov |
| Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,525,168 | January 7, 2020 | December 31, 2025 | KLAUSNER, JEFFREY DAVID | reporter.nih.gov |
| Towards Precision Nutrition for Alzheimer's Dementia Prevention: A Prospective Study of Dietary Patterns, the Gut Microbiome and Cognitive Function | NIH | National Institute on Aging | 2022 to 2025 | $3,513,490 | June 1, 2022 | March 31, 2027 | WANG, DONG | reporter.nih.gov |
| Control of intestinal innate immunity by the commensal microbiota in a model host | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,511,902 | September 24, 2021 | August 31, 2027 | WATNICK, PAULA I | reporter.nih.gov |
| Unraveling gut-microbiome-brain interactions in neurodevelopmental disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $3,503,497 | September 16, 2021 | June 30, 2027 | SAHIN, ERGUN | reporter.nih.gov |
| Spatial Organization of the Oral Microbiome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,495,105 | September 3, 2012 | August 31, 2028 | MARK WELCH, JESSICA LEIGH | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,482,713 | August 14, 2020 | January 13, 2023 | NADEAU, KARI C. | reporter.nih.gov |
| Personalized Dietary Management in Type 2 Diabetes | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,459,318 | January 15, 2021 | November 30, 2026 | POPP, COLLIN JEFFREY | reporter.nih.gov |
| Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,455,616 | February 11, 2020 | January 31, 2026 | ROBINSON-PAPP, JESSICA | reporter.nih.gov |
| Immunobiology of Lung Injury and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,455,443 | January 21, 2019 | December 31, 2024 | MOORE, BETHANY B. | reporter.nih.gov |
| Epidemiologic and molecular basis of the gut-urinary tract axis in urinary tract infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,416,719 | June 12, 2020 | July 31, 2030 | HULTGREN, SCOTT J. | reporter.nih.gov |
| Studies on gut microbiome-joint connections in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,412,637 | April 1, 2021 | February 28, 2027 | ZUSCIK, MICHAEL J | reporter.nih.gov |
| Systematic characterization of bioactive molecules from the human microbiome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,412,560 | June 16, 2022 | May 31, 2027 | ABOU DONIA, MOHAMED | reporter.nih.gov |
| Characterization of Mucosal Lymphocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,410,819 | September 30, 1992 | June 30, 2029 | BLUMBERG, RICHARD S | reporter.nih.gov |
| Microbiota-derived metabolites and the regulation of host immunity and inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,409,847 | June 14, 2022 | May 31, 2027 | ARTIS, DAVID | reporter.nih.gov |
| National Gnotobiotic Resource Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,407,181 | July 1, 2003 | June 30, 2029 | SARTOR, RYAN B | reporter.nih.gov |
| Microbial Community Disruption Following Topical Antimicrobial Application in Staphylococcus aureus-Affected Households | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,400,860 | May 19, 2021 | April 30, 2027 | FRITZ, STEPHANIE ANN | reporter.nih.gov |
| The Gut Microbiome Brain Axis and Preterm Infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,393,142 | May 5, 2021 | January 31, 2026 | CLAUD, ERIKA C | reporter.nih.gov |
| Commensal control of C. difficile virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,372,908 | February 1, 2021 | January 31, 2027 | BRY, LYNN | reporter.nih.gov |
| Multi-method investigation and characterization of the ocular microbiome | NIH | National Eye Institute | 2023 to 2025 | $3,357,381 | July 1, 2023 | June 30, 2027 | DE PAIVA, CINTIA S. | reporter.nih.gov |
| Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging | NIH | National Institute on Aging | 2021 to 2024 | $3,347,408 | August 15, 2020 | May 31, 2026 | SNYDER-CAPPIONE, JENNIFER E | reporter.nih.gov |
| Viral respiratory infections in a tracheostomy cohort: Microbiome-host interplay | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,346,417 | September 21, 2022 | July 31, 2027 | MANSBACH, JONATHAN M | reporter.nih.gov |
| Targeting Clostridioides difficile with microbiome-sparing, resistant-proof anti-toxins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,343,705 | April 1, 2021 | March 31, 2026 | SCHRAMM, VERN L. | reporter.nih.gov |
| Periodontitis Role in Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,340,009 | September 1, 2025 | August 31, 2029 | THUMBIGERE-MATH, VIVEK | reporter.nih.gov |
| Vaginal microbiota transplant to promote Lactobacillus-dominant cervicovaginal communities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,339,208 | September 20, 2021 | August 31, 2027 | MITCHELL, CAROLINE M | reporter.nih.gov |
| A novel mechanism of virulence control in Porphyromonas gingivalis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,328,558 | July 1, 2021 | June 30, 2027 | FRIAS-LOPEZ, JORGE | reporter.nih.gov |
| Socioecological Determinants of Immunoepigenetic Signatures of Diabetes Risk in Indigenous Communities | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,326,115 | July 28, 2021 | April 30, 2027 | MAUNAKEA, ALIKA KEOLAOKALANI | reporter.nih.gov |
| Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $3,318,000 | September 30, 2019 | July 31, 2024 | KNIGHT, ROB | reporter.nih.gov |
| Defining bacterial members of the ocular surface microbiome and assessing stability over time | NIH | National Eye Institute | 2023 to 2025 | $3,305,844 | July 1, 2023 | June 30, 2027 | ST LEGER, ANTHONY J | reporter.nih.gov |
| "A microbiome-dependent bile acid metabolite improves type 2 diabetes." | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,304,418 | January 8, 2021 | December 31, 2026 | SHEU, ERIC GARLAND | reporter.nih.gov |
| The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,299,380 | March 4, 2019 | February 28, 2027 | FAITH, JEREMIAH JAMES | reporter.nih.gov |
| Engineering Transmissible Health | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $3,290,462 | August 6, 2018 | July 31, 2024 | GUILLEMIN, KAREN J | reporter.nih.gov |
| Impact of HIV, oral microbiome and mycobiome on oral HPV persistence | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,289,768 | September 1, 2022 | August 31, 2027 | BURK, ROBERT D | reporter.nih.gov |
| Causes and consequences of interpersonal microbial variation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,283,079 | June 10, 2016 | May 31, 2026 | GOODMAN, ANDREW L | reporter.nih.gov |
| Diet transformation by the microbiome and its impact on bacterial infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,277,659 | August 16, 2022 | May 31, 2027 | GOODMAN, ANDREW L | reporter.nih.gov |
| Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,276,651 | September 23, 2021 | July 31, 2027 | DASARATHY, SRINIVASAN | reporter.nih.gov |
| The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia | NIH | National Cancer Institute | 2022 to 2025 | $3,273,998 | September 1, 2022 | August 31, 2027 | ABRAMS, JULIAN | reporter.nih.gov |
| Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,266,890 | September 21, 2021 | August 31, 2026 | WEITZMANN, MERVYN NEALE | reporter.nih.gov |
| Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,263,901 | September 26, 2022 | June 30, 2027 | LIM, UNHEE | reporter.nih.gov |
| Decoding mutualistic microbiota-B cell interactions in the HIV-1-infected gut: impact on immunological non-responders | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,259,183 | May 7, 2020 | April 30, 2026 | MEHANDRU, SAURABH | reporter.nih.gov |
| Metabolic Responses to an Oral Mixed Meal Tolerance Test: Intra-individual changes, correlates, and prognostic significance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,257,323 | August 20, 2021 | June 30, 2026 | NAYOR, MATTHEW G. | reporter.nih.gov |
| Indoles from commensal microbiota promote mobility during aging | NIH | National Institute on Aging | 2025 | $3,251,767 | September 1, 2025 | August 31, 2029 | KALMAN, DANIEL | reporter.nih.gov |
| New Jersey ECHO | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $3,229,703 | September 1, 2023 | May 31, 2025 | BARRETT, EMILY S | reporter.nih.gov |
| Glycomic Modulation of Gut Microbiome During HIV Infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,228,597 | December 24, 2019 | November 30, 2025 | ABDEL MOHSEN, MOHAMED | reporter.nih.gov |
| Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,222,498 | September 21, 2016 | May 31, 2030 | CAMARGO, CARLOS ARTURO | reporter.nih.gov |
| Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,218,917 | August 15, 2015 | June 30, 2026 | JENQ, ROBERT | reporter.nih.gov |
| Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,216,725 | April 1, 2021 | March 31, 2027 | DIAMOND, MICHAEL S | reporter.nih.gov |
| B cell clonal selection in gut-associated germinal centers | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,203,164 | September 17, 2020 | August 31, 2025 | VICTORA, GABRIEL D | reporter.nih.gov |
| Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,194,826 | January 1, 2025 | December 31, 2026 | SEGAL, LEOPOLDO NICOLAS | reporter.nih.gov |
| Understand biological factors underlying early childhood caries disparity from the oral microbiome in early infancy | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,190,415 | May 1, 2022 | January 31, 2027 | XIAO, JIN | reporter.nih.gov |
| Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,190,228 | July 1, 2022 | June 30, 2027 | DEAN, DEBORAH ANNE | reporter.nih.gov |
| Alanyl-glutamine supplementation of standard treatment for C. difficile infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,184,912 | July 13, 2020 | June 30, 2026 | WARREN, CIRLE ALCANTARA | reporter.nih.gov |
| The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,184,687 | August 2, 2021 | June 30, 2027 | MAJITHIA, AMIT | reporter.nih.gov |
| Developing a bioprinted ventilated lung alveolar platform for investigating microbial interactions and influenza response | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,182,827 | August 19, 2025 | July 31, 2029 | OH, JULIA | reporter.nih.gov |
| Residential Greenness, Airway Microbiome,and Incident Childhood Asthma | NIH | National Institute of Environmental Health Sciences | 2025 | $3,181,155 | September 18, 2025 | September 17, 2029 | ZHU, ZHAOZHONG | reporter.nih.gov |
| Natural History of C. trachomatis urogenital and rectal infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,179,786 | March 20, 2020 | February 28, 2026 | DEAN, DEBORAH ANNE | reporter.nih.gov |
| Is the gut important in multiple joint osteoarthritis? A multimodal investigation in humans and pet dogs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,176,745 | August 5, 2022 | June 30, 2027 | NELSON, AMANDA E | reporter.nih.gov |
| A life course perspective on gut microbiome aging and health in a non-human primate model | NIH | National Institute on Aging | 2021 to 2025 | $3,173,432 | April 15, 2021 | January 31, 2027 | ARCHIE, ELIZABETH | reporter.nih.gov |
| Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) | NIH | National Institute of Mental Health | 2023 to 2025 | $3,165,352 | September 15, 2021 | August 31, 2026 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| Immune Development Across the Life Course: Integrating Exposures and Multi-Omics in the Boston Birth Cohort | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $3,158,931 | September 15, 2022 | June 30, 2027 | WANG, XIAOBIN | reporter.nih.gov |
| Identification and Characterization of Microbial Metabolites in Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,152,946 | May 26, 2022 | April 30, 2027 | XAVIER, RAMNIK J | reporter.nih.gov |
| Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk | NIH | National Cancer Institute | 2021 to 2025 | $3,149,705 | January 15, 2021 | December 31, 2026 | FITZGIBBON, MARIAN L. | reporter.nih.gov |
| Vibrio cholerae antinitrosative stress defenses and gut microbiome interaction | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,145,639 | September 23, 2020 | August 31, 2025 | ZHU, JUN | reporter.nih.gov |
| Microbiome, Environment, and Parkinsons disease (MEP) PESTICIDE EXPOSURES AND THE GUT MICROBIOME IN PARKINSONS DISEASE | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,143,396 | August 15, 2020 | June 30, 2026 | RITZ, BEATE R. | reporter.nih.gov |
| Relationship of fungal translocation, inflammation, and pulmonary function in HIV | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,142,352 | July 10, 2022 | May 31, 2027 | METHE, BARBARA | reporter.nih.gov |
| Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,135,340 | September 21, 2021 | August 31, 2026 | ZARRINPAR, AMIR | reporter.nih.gov |
| Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,134,374 | August 11, 2022 | July 31, 2027 | XIAO, CANHUA | reporter.nih.gov |
| Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,127,515 | June 1, 2022 | May 31, 2027 | BROTMAN, REBECCA M. | reporter.nih.gov |
| Microbiota, Metabolites, and Colon Neoplasia | NIH | National Cancer Institute | 2021 to 2025 | $3,124,761 | May 1, 2021 | April 30, 2027 | ROSENBERG, DANIEL WILLIAM | reporter.nih.gov |
| Structural and functional studies of colibactin | NIH | National Cancer Institute | 2021 to 2025 | $3,124,458 | December 11, 2017 | February 29, 2028 | HERZON, SETH B. | reporter.nih.gov |
| Intestinal microbiota-mediated rotavirus vaccine failure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,123,686 | September 19, 2022 | July 31, 2027 | GEWIRTZ, ANDREW T | reporter.nih.gov |
| Innate lymphoid cell regulation of the host-microbiota interactions in cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,122,275 | September 20, 2022 | August 31, 2027 | SONNENBERG, GREGORY F | reporter.nih.gov |
| MOM2CHild Study: Leveraging systems biology toward discoveries in Maternal Obesity, Milk, and Translation To Child Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,113,115 | August 23, 2022 | May 31, 2027 | MORROW, ARDYTHE L | reporter.nih.gov |
| Microbiota-immune interactions that promote intestinal homeostasis | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,111,145 | June 15, 2021 | May 31, 2026 | ROUND, JUNE LOUISE | reporter.nih.gov |
| Determinants of H. influenzae Virulence in Otitis Media | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,109,258 | September 30, 1999 | December 31, 2026 | GOODMAN, STEVEN D | reporter.nih.gov |
| The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2021 to 2025 | $3,108,327 | January 1, 2021 | December 31, 2026 | ABRAMS, JULIAN | reporter.nih.gov |
| Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,091,749 | September 30, 2021 | July 31, 2027 | APETREI, CRISTIAN | reporter.nih.gov |
| MAEVE: Microbiota mediated flavonoid metabolites for cognitive health | NIH | National Institute on Aging | 2024 to 2025 | $3,084,260 | July 15, 2024 | June 30, 2029 | CHURCH, ARPANA | reporter.nih.gov |
| Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen | NIH | National Cancer Institute | 2021 to 2025 | $3,068,738 | September 13, 2021 | August 31, 2027 | KHAZAIE, KHASHAYARSHA | reporter.nih.gov |
| Detection of pathogen infection by monitoring host cell membrane dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,065,177 | September 22, 2021 | August 31, 2026 | PUKKILA-WORLEY, READ | reporter.nih.gov |
| The Role of the Gut Microbiome and Short Chain Fatty Acids in the Regulation of Inflammation and Neuropsychological Symptoms in Patients with Head and Neck Cancer | NIH | National Institute of Nursing Research | 2022 to 2025 | $3,064,029 | May 9, 2022 | February 28, 2027 | XIAO, CANHUA | reporter.nih.gov |
| The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,059,645 | February 5, 2021 | January 31, 2027 | YU, DANXIA | reporter.nih.gov |
| Development of novel anti-Neisseria gonorrhoeae therapeutic agents | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,055,792 | August 12, 2022 | July 31, 2027 | FLAHERTY, DANIEL PATRICK | reporter.nih.gov |
| Mechanism of action for the epithelial-specific ER stress sensor IRE1β in regulating intestinal homeostasis and host defense | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,050,147 | September 1, 1993 | March 31, 2026 | LENCER, WAYNE I | reporter.nih.gov |
| Building the foundations of commensal vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,047,222 | September 23, 2022 | August 31, 2027 | FISCHBACH, MICHAEL ANDREW | reporter.nih.gov |
| Influence of maternal virome and HIV status on infant gut virome, growth and immunity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,044,222 | September 21, 2020 | August 31, 2025 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| 3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,037,595 | February 25, 2022 | January 31, 2028 | FRIEBOES, HERMANN | reporter.nih.gov |
| Time restricted feeding versus daily calorie restriction: Effect on body weight, metabolic risk, and the gut microbiome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,028,553 | September 14, 2021 | July 31, 2027 | VARADY, KRISTA AMY | reporter.nih.gov |
| Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,027,125 | September 1, 2018 | July 31, 2025 | LAZARIDIS, KONSTANTINOS N | reporter.nih.gov |
| Metapangenomics of the Oral Microbiome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,025,869 | July 1, 2021 | June 30, 2027 | BORISY, GARY G | reporter.nih.gov |
| Study the Treg-IL-27 axis in immune regulation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,022,197 | July 8, 2025 | June 30, 2029 | LU, LI-FAN | reporter.nih.gov |
| Mechanistic basis of bacteriophages for the decolonization of vancomycin resistant enterococci in the intestine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,022,123 | September 14, 2018 | July 31, 2028 | DUERKOP, BRECK A | reporter.nih.gov |
| Uncovering the rules of gut microbiome strain transmission | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,013,179 | January 20, 2020 | December 31, 2028 | FAITH, JEREMIAH JAMES | reporter.nih.gov |
| Dietary Fiber-Microbiome Interactions: Elucidating Mechanisms to Suppress Multi-Drug Resistant Organisms in the Human Gut | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,012,181 | September 10, 2025 | August 31, 2029 | VENTURELLI, OPHELIA | reporter.nih.gov |
| Host and microbial risk factors of oral thrush in cancer patients receiving chemotherapy | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,008,274 | August 4, 2022 | May 31, 2027 | DIAZ, PATRICIA | reporter.nih.gov |
| The impact of bacteriophage therapy on wound infection dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,006,418 | February 2, 2022 | January 31, 2027 | WOZNIAK, DANIEL J | reporter.nih.gov |
| CyberGut: towards personalized human-microbiome metabolic modeling for precision health and nutrition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,006,256 | July 1, 2022 | April 30, 2027 | GIBBONS, SEAN MICHAEL | reporter.nih.gov |
| A consortium facilitation, coordination, and data management center for the HVP | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,000,337 | January 15, 2025 | December 31, 2029 | WHITE, OWEN R | reporter.nih.gov |
| Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,995,731 | August 3, 2020 | April 30, 2026 | KASOJI, SANDEEP | reporter.nih.gov |
| Bacterial biosensors for the prevention of gastrointestinal cancers | NIH | National Cancer Institute | 2021 to 2025 | $2,993,830 | May 18, 2020 | April 30, 2029 | HASTY, JEFF M | reporter.nih.gov |
| Targeting microbial dysbiosis in Food Allergy to restore tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,989,996 | February 25, 2021 | January 31, 2026 | CHATILA, TALAL AMINE | reporter.nih.gov |
| The microbiome and aging in Clostridioides difficile infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,979,948 | May 1, 2022 | April 30, 2026 | YOUNG, VINCENT B | reporter.nih.gov |
| Rapid antimicrobial susceptibility testing directly from urine specimens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,974,719 | April 1, 2021 | March 31, 2024 | BURG, LAWRENCE | reporter.nih.gov |
| The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,964,430 | May 8, 2021 | April 30, 2026 | DRUMMOND, MICHAEL BRADLEY | reporter.nih.gov |
| Dietary Etiologies of Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,960,284 | December 1, 1985 | May 19, 2025 | RIMM, ERIC B | reporter.nih.gov |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | NIH | National Cancer Institute | 2021 to 2024 | $2,958,194 | July 15, 2020 | June 30, 2025 | CAPORASO, JAMES GREGORY | reporter.nih.gov |
| Rapid AST through Metabolic Imaging at Single Cell Level | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,949,272 | December 1, 2018 | June 30, 2027 | CHENG, JI-XIN | reporter.nih.gov |
| FabI Inhibitors as Potent, Gut Microbiome-Sparing Antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,933,391 | June 26, 2023 | May 31, 2028 | HERGENROTHER, PAUL | reporter.nih.gov |
| Intestinal CD4 T cell responses to dietary and microbial antigens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,926,273 | January 1, 2013 | December 31, 2026 | MUCIDA, DANIEL S | reporter.nih.gov |
| Regulation and function of mucosal IgA immune responses to mycobiota in the gut. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,924,410 | June 1, 2021 | May 31, 2027 | ILIEV, ILIYAN DIMITROV | reporter.nih.gov |
| NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUT | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,924,301 | September 20, 2013 | February 28, 2027 | CHOI, HYON K | reporter.nih.gov |
| Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,921,132 | February 4, 2022 | April 30, 2025 | VALLADARES, RICARDO | reporter.nih.gov |
| Commensal-specific T cell function in skin wound repair | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,918,975 | February 1, 2021 | April 30, 2026 | HARRISON, OLIVER JAMES | reporter.nih.gov |
| A Novel Probiotic for the Treatment of Sjogren's Syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,918,422 | May 12, 2021 | April 30, 2026 | FANGER, GARY | reporter.nih.gov |
| Deciphering the role of chemical signals in inflammation with open microfluidic functional assays | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,917,209 | August 1, 2018 | July 31, 2028 | THEBERGE, ASHLEIGH BROOKS | reporter.nih.gov |
| Investigating neurobehavioral consequences of COVID-19 related stressors on maternal mental health and infant development | NIH | National Institute of Mental Health | 2021 to 2024 | $2,914,615 | June 1, 2021 | March 31, 2026 | BRITO, NATALIE HIROMI | reporter.nih.gov |
| New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,903,162 | July 1, 2021 | April 30, 2026 | MOON, JAMES J. | reporter.nih.gov |
| Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tract | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,897,992 | March 3, 2021 | February 28, 2027 | DORAN, KELLY S | reporter.nih.gov |
| Role of CREM in Amebic Colitis and Inflammatory Bowel Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,896,698 | August 1, 1989 | December 31, 2027 | PETRI, WILLIAM A | reporter.nih.gov |
| Enhancement of autoimmunity in type 1 diabetes by gluten | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,890,025 | September 17, 2021 | August 31, 2027 | CHERVONSKY, ALEXANDER V | reporter.nih.gov |
| Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,871,429 | June 1, 2020 | May 31, 2026 | RELMAN, DAVID A. | reporter.nih.gov |
| Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,868,592 | July 15, 2022 | May 31, 2027 | ROUT, NAMITA | reporter.nih.gov |
| Obstructive sleep apnea, the microbiome and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,867,397 | January 1, 2022 | December 31, 2025 | HADDAD, GABRIEL G | reporter.nih.gov |
| Understanding and Harnessing Microbial Reprogramming to Combat Carcinogenic Colibactin in Colorectal Cancer | NIH | National Cancer Institute | 2025 | $2,864,671 | September 10, 2025 | August 31, 2029 | LI, JIAHE | reporter.nih.gov |
| Gut microbiota and human malaria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,860,358 | July 1, 2020 | June 30, 2026 | SCHMIDT, NATHAN | reporter.nih.gov |
| Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,858,390 | September 30, 2022 | July 31, 2027 | FITTING, SYLVIA | reporter.nih.gov |
| Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,856,384 | June 1, 2022 | April 30, 2027 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,855,619 | August 1, 2020 | July 31, 2026 | MACEK, MARK D | reporter.nih.gov |
| Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,850,503 | December 13, 2019 | November 30, 2025 | DEAN, GREGG A | reporter.nih.gov |
| Childhood Allergy and the NeOnatal Environment (CANOE) ECHO Pediatric Follow-Up and New Enrollment | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,848,939 | September 1, 2023 | May 31, 2025 | SINGH, ANNE MARIE | reporter.nih.gov |
| Defining the Role of Enteric Nervous System Dysfunction in Gastrointestinal Motor and Sensory Abnormalities in Down Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,837,478 | May 1, 2023 | April 30, 2026 | BELKIND-GERSON, JAIME | reporter.nih.gov |
| Absorption of vitamin B1 along the intestinal tract: Physiology, pathophysiology and cell biology aspects | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,831,663 | August 1, 1999 | December 31, 2025 | SAID, HAMID M | reporter.nih.gov |
| The Development of Gut Microbiota and Behavioral Inhibition in Childhood: The Role of Early Stress and Brain Development | NIH | National Institute of Mental Health | 2021 to 2024 | $2,820,144 | September 18, 2020 | June 30, 2026 | PROPPER, CATHI BARBRA | reporter.nih.gov |
| Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,818,660 | June 7, 2021 | May 31, 2027 | KUMARASWAMI, MUTHIAH | reporter.nih.gov |
| Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases | NIH | National Library of Medicine | 2021 to 2022 | $2,817,521 | June 3, 2019 | May 31, 2024 | SCOTCH, MATTHEW | reporter.nih.gov |
| Mechanistic pathways of the effects of human-animal interaction on depression and psychosocial stress | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,813,817 | April 1, 2020 | February 28, 2027 | SCHERNHAMMER, EVA S | reporter.nih.gov |
| The role of the intestinal microbiome in cancer immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $2,811,009 | August 1, 2023 | July 31, 2030 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,809,344 | August 1, 2021 | July 31, 2026 | LITTMAN, DAN | reporter.nih.gov |
| Milk-Omics: Systems Biology of Human Milk and Its Links to Maternal and Infant Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,806,298 | September 23, 2022 | August 31, 2027 | DEMERATH, ELLEN W. | reporter.nih.gov |
| ATP-driven detection of foreign proteins triggers diverse mechanisms of cellular defense and phage-mediated counter defense | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,805,764 | February 1, 2020 | April 30, 2030 | WIEDENHEFT, BLAKE A | reporter.nih.gov |
| Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,799,613 | May 1, 2020 | February 28, 2026 | HUSSAIN, SALIK | reporter.nih.gov |
| Micron-scale Spatial Metagenomic Mapping of Microbial Biogeography in the Gastrointestinal Tract | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,799,544 | June 1, 2017 | May 31, 2028 | WANG, HARRIS H | reporter.nih.gov |
| Bacterial metabolites controlling Th17 and Treg cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,799,466 | September 1, 2016 | July 31, 2025 | HUH, JUN R. | reporter.nih.gov |
| Neuro-immune interactions at the intestinal surface | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,799,092 | April 1, 2024 | March 31, 2029 | MUCIDA, DANIEL S | reporter.nih.gov |
| Mechanisms of MRSA intestinal colonization | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,795,502 | January 17, 2020 | December 31, 2025 | SHOPSIN, BO | reporter.nih.gov |
| Vertically transferred antibodies protect babies from Escherichia coli infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,790,604 | September 11, 2025 | August 31, 2029 | WAY, SING SING | reporter.nih.gov |
| Targeting the Meta-organismal Butyrate Pathway to Prevent Arterial Restenosis after Vascular Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,787,567 | April 1, 2021 | March 31, 2027 | HO, KAREN J. | reporter.nih.gov |
| Dietary influence on infant growth and the gut microbiota | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,783,406 | February 2, 2021 | August 15, 2024 | TANG, MINGHUA | reporter.nih.gov |
| Role of RORgt+ (note: g: is gamma symbol) lymphocytes in Gut Tissue Homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,779,710 | August 1, 2021 | July 31, 2027 | ZHOU, LIANG | reporter.nih.gov |
| Treating colon cancer by regulating intestinal immunity through microbial metabolism | NIH | National Cancer Institute | 2021 to 2025 | $2,772,249 | June 1, 2021 | May 31, 2027 | ARPAIA, NICHOLAS | reporter.nih.gov |
| A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity | NIH | National Cancer Institute | 2022 to 2025 | $2,770,577 | February 24, 2022 | January 31, 2027 | DIEFENBACH, CATHERINE SIBYL | reporter.nih.gov |
| The Discovery of Novel Metabolic Pathways for the Biosynthesis and Degradation of Complex Carbohydrates within the Human Gut Microbiome | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,770,488 | February 1, 2021 | January 31, 2027 | RAUSHEL, FRANK M. | reporter.nih.gov |
| Elucidating the Role of Regulatory T cells in Establishing and Maintaining a Th2 Niche in Skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,768,552 | July 10, 2020 | June 30, 2025 | ROSENBLUM, MICHAEL DAVID | reporter.nih.gov |
| Biobehavioral Factors and their Impact on Stress-Related Eating in Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,764,300 | September 21, 2021 | May 31, 2026 | ENGEL, SCOTT G | reporter.nih.gov |
| Gut Flora metabolism of dietary carnitine and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,763,113 | August 1, 2010 | April 30, 2026 | HAZEN, STANLEY L | reporter.nih.gov |
| Environmental Chemical Impact on the Host-Microbiome Interaction | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,749,465 | June 13, 2023 | May 31, 2031 | PATTERSON, ANDREW | reporter.nih.gov |
| Linking microbiome genetic variants with cardiovascular phenotypes in 50,000 individuals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,748,578 | August 1, 2022 | May 31, 2027 | POLLARD, KATHERINE S. | reporter.nih.gov |
| Endoplasmic reticulum stress and intestinal inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,747,810 | May 1, 2010 | March 31, 2030 | BLUMBERG, RICHARD S | reporter.nih.gov |
| Breathprinting as a window into gut microbiome chemoecology | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,742,643 | September 1, 2022 | June 30, 2027 | ODOM JOHN, AUDREY RAGAN | reporter.nih.gov |
| Mechanism of Colonization Resistance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,739,660 | August 20, 2014 | March 31, 2026 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,736,892 | August 1, 2021 | April 30, 2027 | GONZALEZ, OCTAVIO ALBERTO | reporter.nih.gov |
| Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,735,326 | August 1, 2022 | May 31, 2027 | LOZUPONE, CATHERINE | reporter.nih.gov |
| ECHO Renewal for the CANOE Study Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,735,209 | September 1, 2023 | May 31, 2026 | HARTERT, TINA V | reporter.nih.gov |
| Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,727,333 | September 10, 2022 | July 31, 2027 | BARVE, SHIRISH S | reporter.nih.gov |
| Predicting and preventing drug metabolism by the human gut microbiome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,718,950 | March 1, 2016 | July 31, 2026 | TURNBAUGH, PETER JAMES | reporter.nih.gov |
| University of Minnesota Clinical Center for the Study of Pancreatic Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,713,570 | September 3, 2020 | June 30, 2030 | BELLIN, MELENA D. | reporter.nih.gov |
| Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,710,007 | September 19, 2018 | May 31, 2029 | SKAAR, ERIC P | reporter.nih.gov |
| Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,706,539 | July 1, 2017 | January 31, 2028 | MOZAFFARIAN, DARIUSH | reporter.nih.gov |
| Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,705,917 | March 10, 2020 | February 28, 2026 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| Fecal Microbiota Transplant National Registry | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,705,877 | August 4, 2016 | April 30, 2027 | WU, GARY D. | reporter.nih.gov |
| Gut microbiome, enteric infections and child growth across a rurual urban gradient | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,701,254 | January 24, 2018 | December 31, 2025 | LEVY, KAREN | reporter.nih.gov |
| Mechanisms of alteration of gastrointestinal physiology by gut microbes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,700,677 | September 1, 2017 | June 30, 2027 | KASHYAP, PURNA C | reporter.nih.gov |
| Dietary Regulation of Intestinal Inflammation and Repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,700,479 | March 15, 2022 | January 31, 2027 | ARTIS, DAVID | reporter.nih.gov |
| Contribution of the Virome to HIV/AIDS pathogenesis | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,697,396 | February 14, 2020 | May 31, 2026 | KORALNIK, IGOR J. | reporter.nih.gov |
| Host-microbe interactions: Harnessing co-evolution to treat disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,693,600 | September 30, 2018 | July 31, 2024 | AYRES, JANELLE S | reporter.nih.gov |
| Functional Redundancy of Human Microbiome and its Implication in Fecal Microbiota Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,682,798 | August 15, 2019 | July 31, 2025 | LIU, YANG-YU | reporter.nih.gov |
| Gut symbiotic microbiota-derived CD1d ligands and their immunomodulatory mechanisms | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,675,501 | June 14, 2022 | May 31, 2027 | OH, SUNGWHAN F | reporter.nih.gov |
| Link between early gut dysfunction and amyloid beta aggregation in Alzheimer's Disease related dementia | NIH | National Institute on Aging | 2021 to 2025 | $2,672,767 | June 1, 2021 | March 31, 2027 | GANESH, BHANU PRIYA | reporter.nih.gov |
| Neurobiological and neurocognitive consequences of diverse microbiome functional trajectories | NIH | National Institute of Mental Health | 2022 to 2025 | $2,670,235 | July 1, 2022 | May 31, 2027 | GILL, STEVEN R. | reporter.nih.gov |
| Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,669,304 | July 15, 2020 | June 30, 2026 | HARTMAN, TERRYL J. | reporter.nih.gov |
| Comprehensive Training Program in Oral Biology | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,668,959 | July 1, 2011 | June 30, 2027 | LEMOS, JOSE A | reporter.nih.gov |
| Investigating the Influences of Sleep‐Wake Patterns and Gut Microbiome Development in Infancy on Rapid Weight Gain, an Early Risk Factor for Obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,668,382 | February 1, 2020 | January 31, 2026 | PETROV, MEGAN ELISE | reporter.nih.gov |
| A high-performance and versatile technology for precision microbiome engineering | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,652,300 | September 1, 2021 | May 31, 2026 | WANG, HARRIS H | reporter.nih.gov |
| Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,646,037 | January 1, 2018 | April 30, 2027 | QI, LU | reporter.nih.gov |
| Immunity to commensal papillomaviruses for cancer therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,645,679 | May 1, 2021 | April 30, 2027 | DEMEHRI, SHADMEHR | reporter.nih.gov |
| Mindfulness meditation training for Irritable Bowel Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,643,486 | May 4, 2021 | April 30, 2026 | CRESWELL, JOHN DAVID | reporter.nih.gov |
| Microbial regulation of intestinal lipid metabolism and its physiological consequences | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,640,580 | December 3, 2021 | November 30, 2026 | RAWLS, JOHN F | reporter.nih.gov |
| Vibrio fischeri as a Model for Bacterial Colonization | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,639,528 | December 1, 2001 | February 29, 2028 | MC FALL-NGAI, MARGARET J | reporter.nih.gov |
| Gut bacterial metallophores in the development and severity of inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,638,713 | April 1, 2022 | February 28, 2027 | SAMUELSON, DERRICK R | reporter.nih.gov |
| Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,637,479 | August 1, 2023 | July 31, 2028 | RYMAN, SEPHIRA | reporter.nih.gov |
| Coffee and metabolites modulating the gut microbiome for improved colorectal cancer survival | NIH | National Cancer Institute | 2022 to 2025 | $2,628,801 | June 2, 2022 | May 31, 2027 | SONG, MINGYANG | reporter.nih.gov |
| Inflammatory cross-talk between skin and gut | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,627,786 | March 1, 2021 | February 28, 2026 | GALLO, RICHARD L | reporter.nih.gov |
| Discovery of Antibiotics from Soil Microbiomes Using Metagenomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,627,250 | May 1, 2017 | August 31, 2028 | BRADY, SEAN F | reporter.nih.gov |
| Role of epithelial ROS signaling in mediating psychological stress-induced mucosal dysfunction and colitis predisposition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,622,833 | July 31, 2022 | May 31, 2027 | ALLEN, JACOB MATTHEW | reporter.nih.gov |
| Role of the environmental sensor, AhR on colitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,615,887 | September 27, 2021 | August 31, 2027 | NAGARKATTI, PRAKASH S | reporter.nih.gov |
| Reconstructing early life environmental exposures using tooth biomarkers and their influence on the trajectory of the oral microbiome and oral health in childhood | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,614,819 | September 1, 2020 | May 31, 2025 | PETRICK, LAUREN | reporter.nih.gov |
| Systems Genetics Dissection of Non-alcoholic Steatohepatitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,612,818 | July 1, 2019 | March 31, 2028 | LUSIS, ALDONS JAKE | reporter.nih.gov |
| the Gut Microbiome as a Disease Modifier of Heterotopic Ossification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,611,438 | June 1, 2022 | May 31, 2027 | PERRIEN, DANIEL S | reporter.nih.gov |
| The Role of Altered Luminal Dynamics in OSA-Induced Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,610,156 | July 10, 2019 | June 30, 2024 | ZARRINPAR, AMIR | reporter.nih.gov |
| Quorum sensing, diversity and skin inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,599,585 | June 12, 2020 | May 31, 2026 | HORSWILL, ALEXANDER R | reporter.nih.gov |
| Microbiome-mediated therapies for aging and healthspan in marmosets | NIH | National Institute on Aging | 2021 to 2024 | $2,592,378 | September 30, 2020 | May 31, 2025 | ROSS, CORINNA NICOLE | reporter.nih.gov |
| Determining genomic and host-environment contributions to IBD phenotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,592,024 | September 30, 2022 | June 30, 2027 | MCGOVERN, DERMOT PATRICK | reporter.nih.gov |
| Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,589,752 | March 15, 2021 | July 6, 2026 | LITTMAN, DAN | reporter.nih.gov |
| Mechanisms underlying bacterial sensitivity to host-targeted drugs | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,581,834 | June 10, 2022 | May 31, 2027 | MITCHELL, AMIR | reporter.nih.gov |
| Investigation of FadA adhesin from Fusobacterium nucleatum | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,580,121 | September 10, 2020 | August 31, 2026 | HAN, YIPING | reporter.nih.gov |
| The Pathogenesis of Enteric Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,578,362 | February 24, 2021 | January 31, 2027 | FANG, FERRIC C | reporter.nih.gov |
| Micro-TeACH (Microbiome Technology and Analytic Center Hub) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,568,320 | March 10, 2022 | December 31, 2026 | SCHER, JOSE U. | reporter.nih.gov |
| Interactions of dietary protein intake and intestinal resident microbiota affecting susceptibility to persistent Giardia infection and Giardia mediated enteropathy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,566,571 | September 21, 2020 | August 31, 2025 | BARTELT, LUTHER A | reporter.nih.gov |
| Mechanisms of increased susceptibility to pulmonary Nontuberculous Mycobacterial disease in the elderly | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,558,768 | April 16, 2020 | March 31, 2026 | MESSAOUDI, ILHEM | reporter.nih.gov |
| Dietary fiber and soy protein-based microbiome metabolites for IBD prevention | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,557,667 | July 3, 2018 | December 31, 2026 | MARTENS, ERIC C | reporter.nih.gov |
| Childhood follow-up study of obesity and neurodevelopment after perinatal exposure to adjunctive azithromycin prophylaxis for cesarean delivery | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,553,821 | July 20, 2020 | March 31, 2026 | SUBRAMANIAM, AKILA | reporter.nih.gov |
| Understanding Mechanisms and Sex-Differences in Visceral Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,551,050 | September 1, 2023 | May 31, 2028 | INGRAHAM, HOLLY A. | reporter.nih.gov |
| Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,543,302 | February 19, 2021 | January 31, 2027 | KADARA, HUMAM | reporter.nih.gov |
| The unleashed microbiome of cancer patients as a discovery platform for rational microbiome engineering | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,542,500 | August 13, 2021 | July 31, 2026 | SCHLUTER, JONAS | reporter.nih.gov |
| The Microbiome and Biological Aging in the Add Health Study | NIH | National Institute on Aging | 2021 to 2024 | $2,535,606 | June 15, 2020 | March 31, 2026 | KRAUTER, KENNETH S | reporter.nih.gov |
| Oral Streptococcal Fitness And Virulence genes | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,521,135 | August 3, 2021 | July 31, 2027 | XU, PING | reporter.nih.gov |
| Host's and microbiota's contribution to sexual dimorphism of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,515,770 | August 16, 2017 | November 30, 2027 | CHERVONSKY, ALEXANDER V | reporter.nih.gov |
| Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA | NIH | National Cancer Institute | 2022 to 2025 | $2,514,943 | May 1, 2022 | April 30, 2027 | WALLACE, DOUGLAS C | reporter.nih.gov |
| Methods to Test the Role of Age-related Lifestyle and Vaginal Microenvironment Changes and the Prevention, Treatment, and Progression of Genitourinary Syndrome of Menopause | NIH | National Institute on Aging | 2021 to 2025 | $2,513,445 | September 1, 2021 | May 31, 2027 | SHARDELL, MICHELLE DENISE | reporter.nih.gov |
| Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,513,409 | May 1, 2021 | February 28, 2026 | UNDERHILL, DAVID M. | reporter.nih.gov |
| Dosing and Pilot Efficacy of 2'-Fucosyllactose in Inflammatory Bowel Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,512,710 | July 12, 2018 | June 30, 2027 | DENSON, LEE ARMISTEAD | reporter.nih.gov |
| Childhood Pulmonary and Related Outcomes after Perinatal Exposure to Adjunctive Azithromycin Prophylaxis for Cesarean Delivery (C/SOAP Follow-Up Study) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,507,843 | January 20, 2020 | August 31, 2025 | SUBRAMANIAM, AKILA | reporter.nih.gov |
| Mechanisms of Gastrointestinal COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,503,469 | July 15, 2022 | June 30, 2027 | CIORBA, MATTHEW AARON | reporter.nih.gov |
| Harnessing Antibody Responses to Prevent and Treat Urinary Tract Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,502,664 | November 10, 2021 | October 31, 2026 | KAU, ANDREW LEON | reporter.nih.gov |
| Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients | NIH | National Cancer Institute | 2022 to 2025 | $2,501,120 | June 13, 2022 | May 31, 2027 | KAPILA, YVONNE L | reporter.nih.gov |
| Developmental flame retardant exposure, gut microbiome, and obesity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,499,218 | January 1, 2019 | September 11, 2025 | CUI, JULIA YUE | reporter.nih.gov |
| Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,496,867 | September 18, 2014 | March 31, 2026 | SONNENBURG, JUSTIN L | reporter.nih.gov |
| Development of standardized resources for characterization of the resident ocular surface microbiome. | NIH | National Eye Institute | 2023 to 2025 | $2,493,155 | July 1, 2023 | June 30, 2027 | ENSIGN, LAURA | reporter.nih.gov |
| Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial Vaginosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,488,193 | February 1, 2020 | January 31, 2026 | MUZNY, CHRISTINA A | reporter.nih.gov |
| Amphiregulin-Immunometabolism axis in oral immunity and inflammation during HIV infection | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,487,093 | June 1, 2022 | May 31, 2027 | PANDIYAN, PUSHPA | reporter.nih.gov |
| Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,483,137 | January 15, 2020 | June 30, 2030 | HAND, TIMOTHY WESLEY | reporter.nih.gov |
| Tolerance defenses in host-microbiota interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,482,877 | May 10, 2015 | March 31, 2026 | AYRES, JANELLE S | reporter.nih.gov |
| PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders? | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,479,948 | February 1, 2020 | November 30, 2025 | LEHMLER, HANS-JOACHIM | reporter.nih.gov |
| The role of a bifunctional mucinase in modulating personalized gut microbiota-Vibrio cholerae interactions during infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,477,524 | June 1, 2023 | May 31, 2028 | ZHU, JUN | reporter.nih.gov |
| Topical Vitamin D and Periodontal Disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,472,056 | April 2, 2021 | March 31, 2026 | DIAMOND, GILL | reporter.nih.gov |
| Human Gut Microbiome and Incident Diabetes Risk in U.S. Populations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,470,030 | January 19, 2021 | December 31, 2025 | SUN, QI | reporter.nih.gov |
| Gut microbial fermentation products of muscle-derived lactate as mediators of exercise and metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,469,326 | April 1, 2022 | March 31, 2027 | KOSTIC, ALEKSANDAR DAVID | reporter.nih.gov |
| Domestication and characterization of TM7-the most elusive oral phylum | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,466,563 | September 1, 2024 | August 31, 2029 | HE, XUESONG | reporter.nih.gov |
| The Young Gut Microbiome: A Fountain of Youth for Brain Injury in the Aged? | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,466,010 | April 1, 2024 | August 31, 2026 | SCHWULST, STEVEN J | reporter.nih.gov |
| Single arm trial of menstrual cups among economically vulnerable women to reduce Bacterial vaginosis and STIs through reduced harmful sexual and menstrual practices | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,463,754 | August 1, 2025 | July 31, 2027 | MEHTA, SUPRIYA DINESH | reporter.nih.gov |
| High-resolution, virome-wide infection analysis in type 1 diabetes birth cohorts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,459,418 | June 1, 2024 | May 31, 2027 | ALTIN, JOHN | reporter.nih.gov |
| The Microbiome-Gut-Brain Axis and Personalized Mediterranean Diet Interventions for Alzheimer's Dementia Prevention | NIH | National Institute on Aging | 2024 | $2,451,933 | May 15, 2024 | April 30, 2027 | WANG, DONG | reporter.nih.gov |
| Control of GVHD by Probiotics with individual Commensal Bacteria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,448,717 | May 5, 2022 | April 30, 2027 | YU, XUE-ZHONG | reporter.nih.gov |
| Host integration of commensal and pathogenic bacterial-derived signals | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,446,303 | June 4, 2018 | May 31, 2027 | ALENGHAT, THERESA | reporter.nih.gov |
| Aging, macrophage mediators, and burn trauma: Supplement | NIH | National Institute on Aging | 2021 to 2024 | $2,445,102 | February 1, 2001 | May 31, 2026 | KOVACS, ELIZABETH J. | reporter.nih.gov |
| Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,441,424 | January 22, 2020 | December 31, 2025 | FENG, HANPING | reporter.nih.gov |
| Role of the gut microbiome in the bone loss induced by hyperparathyroidism in mice and humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,440,273 | February 1, 2021 | January 31, 2026 | PACIFICI, ROBERTO | reporter.nih.gov |
| Early life regulation of microbiota specific thymic T cell development | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,439,253 | November 7, 2022 | October 31, 2027 | BETTINI, MATTHEW | reporter.nih.gov |
| Trauma, the gut, and the brain: the gut microbiota-microglia axis in traumatic brain injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,439,002 | August 1, 2022 | July 31, 2027 | SCHWULST, STEVEN J | reporter.nih.gov |
| A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy | NIH | National Cancer Institute | 2021 to 2024 | $2,436,171 | April 1, 2021 | June 30, 2026 | FANGER, GARY | reporter.nih.gov |
| A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis | NIH | National Institute on Aging | 2023 to 2025 | $2,434,680 | September 4, 2023 | June 30, 2027 | FANGER, GARY | reporter.nih.gov |
| The Role in OAT1 in Uremia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,431,655 | January 15, 2017 | July 31, 2026 | NIGAM, SANJAY K | reporter.nih.gov |
| Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,431,360 | February 15, 2021 | January 31, 2027 | LI, CHUNHAO CHRIS | reporter.nih.gov |
| Gut microbial metabolites and risk of coronary heart disease: a prospective, multiethnic, metabolomic study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,429,547 | July 15, 2020 | June 30, 2025 | YU, DANXIA | reporter.nih.gov |
| Role of dietary fiber-microbiota Interactions in the development and function of small intestinal T cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,421,990 | September 1, 2021 | July 31, 2026 | CERVANTES BARRAGAN, LUISA | reporter.nih.gov |
| A scalable platform for highly-multiplexed analysis of antibody reactivity from <1uL of blood | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,420,790 | April 10, 2020 | March 31, 2025 | ALTIN, JOHN | reporter.nih.gov |
| Deciphering the crosstalk between bacteria and their mammalian hosts | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,416,405 | September 1, 2025 | August 31, 2027 | WHITELEY, AARON THOMAS | reporter.nih.gov |
| Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,414,163 | February 1, 2019 | January 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| Virome and Immune Responses associated with IA and Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,412,388 | March 5, 2024 | January 31, 2027 | LLOYD, RICHARD E | reporter.nih.gov |
| Molecular basis of heme scavenging by Gram-positive bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,409,544 | January 19, 2021 | December 31, 2026 | CLUBB, ROBERT THOMPSON | reporter.nih.gov |
| Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,405,842 | February 15, 2016 | January 31, 2026 | LAU, KEN S | reporter.nih.gov |
| MicroRNA Predictors of HIV Risk in Reproductive Age Women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,402,650 | May 13, 2019 | March 31, 2025 | FICHOROVA, RAINA N. | reporter.nih.gov |
| Web-Based Resource for Genomic Enzymology Tools | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,402,510 | January 10, 2022 | December 31, 2026 | GERLT, JOHN A | reporter.nih.gov |
| Leveraging early-life microbes to prevent type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,398,489 | April 1, 2023 | February 29, 2028 | SILVERMAN, MICHAEL A | reporter.nih.gov |
| The Gut Microbiome, Lifestyle, and Colorectal Neoplasia | NIH | National Cancer Institute | 2022 to 2025 | $2,397,399 | May 1, 2022 | April 30, 2027 | SONG, MINGYANG | reporter.nih.gov |
| Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,396,349 | May 11, 2023 | January 31, 2028 | BEBELL, LISA M | reporter.nih.gov |
| Maternal diet and programming of offspring gut-brain axis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,395,660 | June 30, 2022 | April 30, 2027 | TAMASHIRO, KELLIE L. K. | reporter.nih.gov |
| Functional Dissection of Regulatory Myeloid Cells in Microbe-Immune Crosstalk in Skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,391,981 | April 7, 2022 | January 31, 2027 | SCHARSCHMIDT, TIFFANY CRAWFORD | reporter.nih.gov |
| Annotating carbohydrate structures to develop markers for consumption of food | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,391,222 | April 1, 2020 | December 31, 2025 | LEBRILLA, CARLITO B | reporter.nih.gov |
| How sex, host microenvironment, and immune responses shape acquisition of genital bacteria that increase HIV risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,387,782 | December 1, 2021 | November 30, 2026 | LIU, CINDY | reporter.nih.gov |
| Immunological and Microbial Mechanisms in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,387,215 | November 21, 2016 | January 31, 2028 | CHATILA, TALAL AMINE | reporter.nih.gov |
| Roles of sialidase in G. vaginalis-host interactions during bacterial vaginosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,385,117 | December 1, 2014 | November 30, 2025 | LEWIS, AMANDA L. | reporter.nih.gov |
| Sulfide metabolism and signaling | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,381,639 | January 1, 2019 | December 31, 2028 | BANERJEE, RUMA V | reporter.nih.gov |
| Commensal Candida albicans primed Th17 immunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,379,060 | July 1, 2023 | June 30, 2028 | WAY, SING SING | reporter.nih.gov |
| Unraveling strain-level variation in the induction of anti-inflammatory responses in the intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,378,553 | January 1, 2021 | December 31, 2026 | AHERN, PHILIP PATRICK | reporter.nih.gov |
| Fungal dysbiosis regulation of post-influenza bacterial pneumonia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,376,545 | July 16, 2021 | June 30, 2025 | CHEN, PETER | reporter.nih.gov |
| Pore Formation by Cholesterol Dependent Cytolysins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,375,765 | April 1, 1997 | March 31, 2027 | TWETEN, RODNEY K. | reporter.nih.gov |
| Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,375,036 | August 28, 2023 | July 31, 2028 | O'CONNOR, MEGAN A | reporter.nih.gov |
| Acute kidney injury and microbiome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,372,693 | July 15, 2020 | April 30, 2026 | RABB, HAMID | reporter.nih.gov |
| The Role of the Intestinal Mycobiome in Alcoholic Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,368,040 | June 1, 2017 | March 31, 2027 | SCHNABL, BERND G. | reporter.nih.gov |
| MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,366,065 | September 19, 2023 | July 31, 2028 | KASHYAP, PURNA C | reporter.nih.gov |
| Integration of mononuclear phagocytes into the human gastrointestinal GOFlowChip for investigation of luminal antigen sampling | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $2,363,783 | September 30, 2019 | June 30, 2025 | WALK, SETH T | reporter.nih.gov |
| Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy | NIH | National Cancer Institute | 2023 to 2025 | $2,362,235 | September 8, 2023 | August 31, 2028 | GAO, SHOU-JIANG | reporter.nih.gov |
| Immunologic and Imaging studies with TNF Therapy in Prodromal Synucleinopathies | NIH | National Institute on Aging | 2025 | $2,361,361 | September 1, 2025 | August 31, 2030 | CEDARBAUM, JESSE | reporter.nih.gov |
| Dissecting the modulatory functions of interleukin-17 in Alzheimer's Disease | NIH | National Institute on Aging | 2023 | $2,359,602 | December 15, 2022 | November 30, 2025 | HUH, JUN R. | reporter.nih.gov |
| Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children with Newly Diagnosed Diabetes.” | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,359,048 | May 1, 2023 | April 30, 2029 | LENNERZ, BELINDA S | reporter.nih.gov |
| Bayesian multivariate 3D spatial modeling for microbiome image analysis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,357,728 | May 4, 2021 | February 28, 2026 | STARR, JACQUELINE R | reporter.nih.gov |
| Investigating Immune-Microbiome interactions during treatment of Clostridioides difficile with fecal microbiome transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,357,199 | February 5, 2021 | January 31, 2027 | ABT, MICHAEL C. | reporter.nih.gov |
| Gut pathogen virulence and its therapeutic modulation during surgical injury | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,357,080 | February 1, 2001 | March 31, 2027 | ALVERDY, JOHN C | reporter.nih.gov |
| Microbiome Function in Atopic Dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,356,653 | May 1, 2020 | April 30, 2027 | GALLO, RICHARD L | reporter.nih.gov |
| Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,355,154 | September 21, 2021 | July 31, 2026 | BOGYO, MATTHEW | reporter.nih.gov |
| Treponema - Host Cell and Tissue Interactions | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,355,086 | July 1, 2015 | January 31, 2027 | FENNO, J CHRISTOPHER | reporter.nih.gov |
| Kidney Stone Disease In ADPKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,353,533 | September 22, 2021 | June 30, 2027 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Nutritional immunity and microbial competition during Clostridioides difficile infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,352,660 | June 13, 2022 | May 31, 2027 | SKAAR, ERIC P | reporter.nih.gov |
| Caries resistance mechanisms in high-risk Indigenous children | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,350,281 | April 4, 2023 | March 31, 2028 | BIDLACK, FELICITAS B | reporter.nih.gov |
| Quorum Sensing Regulation of EHEC Virulence Genes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,346,135 | January 1, 2023 | December 31, 2027 | SPERANDIO, VANESSA | reporter.nih.gov |
| Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,344,291 | August 18, 2023 | July 31, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Human microbiome metabolites in health and disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,343,863 | July 1, 2018 | June 30, 2028 | DEVLIN, ABIGAIL SLOAN | reporter.nih.gov |
| Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,339,515 | March 22, 2023 | February 29, 2028 | GEHA, RAIF SALIM | reporter.nih.gov |
| Connecting the Spatiotemporal Organization of Gut Bacterial Communities to the Emergence and Spread of Antibiotic Resistance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,339,120 | May 5, 2021 | October 31, 2026 | WILES, TRAVIS J | reporter.nih.gov |
| Diet-derived oxysterols shape intestinal B cell fate by controlling intracellular cholesterol metabolism | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,336,135 | June 25, 2021 | May 31, 2027 | REBOLDI, ANDREA | reporter.nih.gov |
| The natural history of C. trachomatis urethral infections in men who have sex with women | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,335,516 | July 5, 2023 | June 30, 2028 | NELSON, DAVID EMMET | reporter.nih.gov |
| Prenatal and Postnatal Mitochondrial Dysfunction in the Pathogenesis of Necrotizing Enterocolitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,334,824 | September 1, 2025 | August 31, 2029 | HACKAM, DAVID J | reporter.nih.gov |
| Role of colonic enteroendocrine cells in metabolic control | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,334,511 | August 1, 2022 | May 31, 2027 | BURSTEIN, EZRA | reporter.nih.gov |
| Development of Engineered Native Bacteria as a Tool for Functional Manipulation of the Gut Microbiome | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,332,857 | June 20, 2023 | May 31, 2028 | ZARRINPAR, AMIR | reporter.nih.gov |
| Impact of symbiotic protists on intestinal T cell homeostasis and inflammation. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,328,152 | March 1, 2021 | February 28, 2026 | HOWITT, MICHAEL R | reporter.nih.gov |
| Aldehydes in Alcohol-Induced Organ Injury | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,325,195 | September 30, 2010 | February 29, 2028 | ZHOU, ZHANXIANG | reporter.nih.gov |
| Defining Sex-Specific Systemic and Gut Inflammatory Profiles in People Living with HIV | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,321,996 | January 3, 2023 | December 31, 2027 | SMITH, STACEY ABIGAIL | reporter.nih.gov |
| PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,321,738 | June 19, 2023 | May 31, 2028 | DOWNES, KEVIN JAMES | reporter.nih.gov |
| Microbiota, Probiotic and Dietary Metabolite Control of Enteric Pathogen Virulence | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,318,817 | November 10, 2022 | October 31, 2027 | HANG, HOWARD C | reporter.nih.gov |
| DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,315,838 | September 28, 2015 | June 30, 2025 | FISHER, WILLIAM E | reporter.nih.gov |
| Investigations of Lyme spirochete transmission as a complex network of microbial and ecological interactions | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,315,379 | September 16, 2022 | July 31, 2027 | COURET, JANNELLE | reporter.nih.gov |
| Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,310,254 | April 6, 2020 | March 31, 2027 | BECK, LISA ANN | reporter.nih.gov |
| Microbiota outgrowth by Salmonella | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,306,740 | May 1, 2011 | June 30, 2026 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,305,974 | March 1, 2022 | February 28, 2027 | FEDIRKO, VERONIKA | reporter.nih.gov |
| How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,302,945 | July 1, 2022 | June 30, 2027 | HADJIFRANGISKOU, MARIA | reporter.nih.gov |
| Fecal microbiota transplant for Alcohol-Associated Cirrhosis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,300,878 | September 12, 2022 | August 31, 2027 | BAJAJ, JASMOHAN S | reporter.nih.gov |
| The impact of upper gastrointestinal dysmotility on aspiration-associated aerodigestive disorders in children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,300,603 | July 1, 2015 | May 31, 2027 | ROSEN, RACHEL L | reporter.nih.gov |
| Metabolism of cancer chemotherapeutics by the human gut microbiome | NIH | National Cancer Institute | 2023 to 2025 | $2,300,078 | September 1, 2023 | August 31, 2028 | TURNBAUGH, PETER JAMES | reporter.nih.gov |
| Neonatal gut-on-a-chip platform for high content drug testing and precision medicine | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,297,962 | April 1, 2022 | August 31, 2025 | GOOD, MISTY L | reporter.nih.gov |
| Balanced Energy Protein Supplement in Early Lactation on Infant Growth in Southern Nepal | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,290,371 | September 19, 2022 | July 31, 2027 | ERCHICK, DANIEL JOSEPH | reporter.nih.gov |
| Immune Interactions with the Mucus-Associated Microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,287,659 | July 12, 2021 | June 30, 2027 | MAYNARD, CRAIG L | reporter.nih.gov |
| Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,286,893 | June 1, 2020 | May 31, 2026 | GNJATIC, SACHA | reporter.nih.gov |
| Fitness Effects of Beneficial Mutations | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,286,190 | May 1, 2019 | April 30, 2029 | SHERLOCK, GAVIN J | reporter.nih.gov |
| LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,285,261 | May 1, 2022 | April 30, 2027 | HOLGUIN, FERNANDO | reporter.nih.gov |
| Goblet Cells in Intestinal Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,283,637 | September 17, 2012 | June 30, 2027 | NEWBERRY, RODNEY D | reporter.nih.gov |
| Microbiota-based probiotics to treat inborn errors in metabolism | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,280,969 | February 16, 2022 | January 31, 2027 | DODD, DYLAN | reporter.nih.gov |
| Activity Probes to Guide Precision Microbiome Therapy | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,279,811 | September 1, 2024 | May 31, 2029 | LONGMAN, RANDY S | reporter.nih.gov |
| Role of the oral microbiome in driving local and systemic inflammation in HIV | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,277,570 | August 1, 2023 | July 31, 2028 | FULCHER, JENNIFER | reporter.nih.gov |
| Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,277,552 | September 21, 2021 | June 30, 2027 | PATRAS, KATY | reporter.nih.gov |
| A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,277,236 | July 5, 2022 | July 31, 2025 | FANGER, GARY | reporter.nih.gov |
| Understanding redox-regulated mechanisms of environmental adaptation in gastrointestinal symbionts | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,272,455 | August 1, 2020 | May 31, 2030 | HATZIOS, STAVROULA | reporter.nih.gov |
| Integrative and longitudinal multi-omic risk assessment in inflammatory bowel disease progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,272,364 | September 30, 2022 | June 30, 2027 | KUGATHASAN, SUBRA | reporter.nih.gov |
| Metabolic Basis of Bacterial Community Function in the Cystic Fibrosis Airway | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,268,565 | June 2, 2021 | May 31, 2026 | O'TOOLE, GEORGE A. | reporter.nih.gov |
| Reducing innate inflammation in new onset T1D with Lactobacillus plantarum | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,267,995 | August 21, 2020 | May 31, 2026 | HESSNER, MARTIN J | reporter.nih.gov |
| Pathogenesis of Early Onset Colorectal Cancer: Microbiome Contributions and Mechanisms | NIH | National Cancer Institute | 2021 to 2025 | $2,266,043 | September 23, 2021 | August 31, 2026 | SEARS, CYNTHIA | reporter.nih.gov |
| Defining non-genetic mechanisms that prevent death in a Hirschsprung disease mouse model | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,261,547 | August 27, 2021 | May 31, 2026 | HEUCKEROTH, ROBERT O | reporter.nih.gov |
| Exacerbation of Colitis by Enterobacteriaceae | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,260,715 | January 15, 2015 | March 31, 2026 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Repurposing of Metormin for Older Patients with HFpEF | NIH | National Institute on Aging | 2022 to 2024 | $2,257,874 | August 1, 2022 | July 31, 2026 | KITZMAN, DALANE W | reporter.nih.gov |
| Role of Type 2 Immunity in Innate Protection from C. difficile | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,257,824 | February 2, 2016 | January 31, 2027 | PETRI, WILLIAM A | reporter.nih.gov |
| Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT) | NIH | National Institute of Mental Health | 2021 to 2023 | $2,257,672 | September 15, 2021 | September 2, 2023 | CARRICO, ADAM WAYNE | reporter.nih.gov |
| Host-associated biofilm formation and dispersal mechanisms | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,257,572 | May 1, 2019 | April 30, 2029 | VISICK, KAREN L | reporter.nih.gov |
| Whole Body Deep Tissue Characterization of the Human Virome | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,255,898 | September 13, 2024 | August 31, 2029 | HENRICH, TIMOTHY JENSEN | reporter.nih.gov |
| Microbial regulation of mammalian circadian rhythms and the sexual dimorphism: from metabolism to immunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,254,500 | September 19, 2022 | August 31, 2027 | KUANG, ZHENG | reporter.nih.gov |
| Tryptophan derivatives in EHEC pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,253,769 | August 8, 2022 | January 31, 2027 | SPERANDIO, VANESSA | reporter.nih.gov |
| Collaborative Microbial Metabolite Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,248,758 | September 1, 2022 | June 30, 2027 | DORRESTEIN, PIETER C | reporter.nih.gov |
| The Microbiome and Mucosal Immunity in Cervical Cancer Disparities | NIH | National Cancer Institute | 2022 to 2025 | $2,247,793 | April 25, 2022 | March 31, 2027 | BURGENER, ADAM | reporter.nih.gov |
| ß-hydroxybutyrate inhibition of pathology in Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2025 | $2,247,073 | August 1, 2023 | July 31, 2028 | ULLAND, TYLER KENT | reporter.nih.gov |
| Lipid-dependent host-microbe interactions | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,245,604 | August 1, 2020 | May 31, 2030 | JOHNSON, ELIZABETH L | reporter.nih.gov |
| Culture-free pathogen tracking in hospitalized patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,245,086 | April 3, 2020 | March 31, 2025 | BHATT, AMI SIDDHARTH | reporter.nih.gov |
| Bacterial adaptions in host-microbe interactions. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,240,628 | March 11, 2022 | February 28, 2027 | CHU, HIUTUNG | reporter.nih.gov |
| Machine Learning and Control Principles for Computational Biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,237,500 | September 1, 2021 | August 31, 2026 | GIBSON, TRAVIS ELI | reporter.nih.gov |
| Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction | NIH | National Institute on Aging | 2021 to 2024 | $2,237,377 | September 10, 2020 | May 31, 2026 | ZHOU, YANJIAO | reporter.nih.gov |
| Positive Immune-regulators During Chronic Viral Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,236,668 | February 1, 2015 | June 30, 2025 | ZUNIGA, ELINA I | reporter.nih.gov |
| Determinants of the periocular microbiome | NIH | National Eye Institute | 2023 to 2025 | $2,236,328 | July 1, 2023 | June 30, 2026 | VAN GELDER, RUSSELL N. | reporter.nih.gov |
| Microbial reactivation of sex steroids and visceral pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,236,187 | August 1, 2022 | May 31, 2027 | RAO, MEENAKSHI | reporter.nih.gov |
| Oral Epithelial Cells, Candida and PMN Activation | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,233,413 | September 29, 2000 | July 31, 2026 | DONGARI-BAGTZOGLOU, ANNA I | reporter.nih.gov |
| A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,232,732 | July 1, 2023 | June 30, 2028 | RAHME, LAURENCE G | reporter.nih.gov |
| A multiscale approach to develop and apply fluoride efflux inhibitors to reverse oral dysbiosis and eliminate early childhood caries | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $2,229,042 | September 12, 2024 | June 30, 2029 | STOCKBRIDGE, RANDY B. | reporter.nih.gov |
| CANCAN - COLDSPRING | NIH | National Cancer Institute | 2022 to 2025 | $2,225,345 | June 22, 2022 | May 31, 2026 | JANOWITZ, TOBIAS | reporter.nih.gov |
| Maintenance of mucosal homeostasis by commensal Th17 cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,225,217 | August 6, 2021 | May 31, 2026 | IVANOV, IVAYLO IVANOV | reporter.nih.gov |
| PROSPECT-Global Consortium and Risk Factor Discovery | NIH | National Cancer Institute | 2024 to 2025 | $2,222,328 | May 1, 2024 | April 30, 2026 | CAO, YIN | reporter.nih.gov |
| Dynamic changes in virome-host interactions during pregnancy and postpartum | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,222,038 | September 17, 2024 | August 31, 2029 | WYLIE, KRISTINE M. | reporter.nih.gov |
| Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology | NIH | National Cancer Institute | 2021 to 2025 | $2,221,814 | March 18, 2011 | July 31, 2027 | GARRETT, WENDY S. | reporter.nih.gov |
| Gut-microbial metabolism of aromatic amino acids and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,221,265 | December 15, 2021 | November 30, 2026 | NEMET, INA | reporter.nih.gov |
| Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,216,742 | April 22, 2020 | September 30, 2024 | GHADIRI, M. REZA | reporter.nih.gov |
| Relating impacts of antibiotics on the gut metabolome and microbiome to host physiology and weight | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,214,927 | August 1, 2020 | May 31, 2026 | BELENKY, PETER | reporter.nih.gov |
| Prenatal neuroinflammation: maternal microbiome contributions and behavioral consequences | NIH | National Institute of Mental Health | 2022 to 2025 | $2,209,338 | May 1, 2022 | February 28, 2027 | GUR, TAMAR | reporter.nih.gov |
| Systemic immunoregulatory consequences of bacterial translocation during health and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,209,196 | September 21, 2021 | June 30, 2026 | MEISEL, MARLIES | reporter.nih.gov |
| Dissecting the Source and Mechanisms of IL-17-Mediated Modulation of Pancreatic Tumorigenesis | NIH | National Cancer Institute | 2021 to 2025 | $2,204,373 | September 18, 2020 | August 31, 2027 | MCALLISTER, FLORENCIA | reporter.nih.gov |
| Strengthening gut barrier integrity with beneficial microbes to increase lifespan and healthspan | NIH | National Institute on Aging | 2022 to 2025 | $2,197,864 | September 15, 2021 | May 31, 2027 | CROTT, JIMMY W | reporter.nih.gov |
| In vivo mechanisms mediating sickle cell vaso-occlusion and organ damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,197,616 | September 30, 2001 | August 31, 2025 | KELLY, LIBUSHA | reporter.nih.gov |
| Microbial regulation of the keratinocyte AHR | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,197,247 | April 1, 2022 | March 31, 2027 | GRICE, ELIZABETH ANNE | reporter.nih.gov |
| Molecular and cellular mechanisms in food anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,192,068 | June 1, 2020 | May 31, 2025 | GEHA, RAIF SALIM | reporter.nih.gov |
| Blocking CMV transmission through the human milk metabolome and microbiome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,191,788 | April 1, 2021 | March 31, 2026 | MARQUEZ-LAGO, TATIANA T. | reporter.nih.gov |
| Alcohol and Burn Trauma: Multi-organ Inflammatory Responses | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,191,572 | September 20, 2019 | June 30, 2029 | KOVACS, ELIZABETH J. | reporter.nih.gov |
| Regulation of Gut Innate Lymphoid Cells by Ahr | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,190,711 | July 15, 2017 | June 30, 2028 | ZHOU, LIANG | reporter.nih.gov |
| Environmental factors in pathobiology of dementia: the role of PCB exposure, microbiome, and tissue barrier dysfunction | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,186,707 | January 1, 2023 | November 30, 2026 | LEHMLER, HANS-JOACHIM | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Leidos Biomedical Research, Inc. | Frederick, MD | 1 | $2.96 billion | 0 | $0 |
| Washington University | Saint Louis, MO | 92 | $155.9 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 76 | $133.2 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 61 | $101.3 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 54 | $77.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 46 | $77.1 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 48 | $73.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 78 | $73.3 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 80 | $72.7 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 72 | $69.5 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 57 | $69.1 million | 0 | $0 |
| University of Chicago | Chicago, IL | 45 | $66.3 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 52 | $66 million | 0 | $0 |
| Duke University | Durham, NC | 51 | $62.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 57 | $61.1 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 38 | $61.1 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 40 | $60.2 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 57 | $59.9 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 37 | $55 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 55 | $54.9 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 53 | $50.9 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 48 | $49.7 million | 0 | $0 |
| University of Washington | Seattle, WA | 46 | $49.7 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 12 | $48.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 48 | $47.6 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 22 | $47.4 million | 0 | $0 |
| Yale University | New Haven, CT | 35 | $47 million | 0 | $0 |
| University of Florida | Gainesville, FL | 52 | $46.5 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 47 | $45.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 13 | $45.2 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 18 | $44.9 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 17 | $42.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 49 | $42.5 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 22 | $42 million | 0 | $0 |
| University of California at Davis | Davis, CA | 40 | $39.8 million | 0 | $0 |
| University of Louisville | Louisville, KY | 26 | $39.8 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 25 | $32.5 million | 0 | $0 |
| Rho Federal Systems Division, Inc. | Durham, NC | 1 | $32.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 23 | $30.8 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 26 | $30.6 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 10 | $30.1 million | 0 | $0 |
| Ada Forsyth Institute, Inc. | Somerville, MA | 18 | $29.8 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 33 | $29.1 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 8 | $28.7 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 26 | $27.8 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 21 | $27.7 million | 0 | $0 |
| National Jewish Health | Denver, CO | 1 | $27.2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 33 | $26.9 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 3 | $26.8 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 11 | $26 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 15 | $26 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 20 | $25.7 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 25 | $25.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 43 | $25.4 million | 0 | $0 |
| Cold Spring Harbor Laboratory | Cold Spring Harbor, NY | 5 | $24.9 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 21 | $24.8 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 8 | $24.7 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 19 | $24.2 million | 0 | $0 |
| University of Rochester | Rochester, NY | 16 | $23.3 million | 0 | $0 |
| Rise Therapeutics, LLC | Rockville, MD | 12 | $23.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 28 | $22.4 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 19 | $22.1 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 14 | $21.8 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 23 | $21.3 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 23 | $21.2 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 11 | $20.9 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 18 | $20.8 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 14 | $19.4 million | 0 | $0 |
| Cornell University | Ithaca, NY | 18 | $18.8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 9 | $18 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 15 | $17.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 17 | $16.9 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 21 | $16.8 million | 0 | $0 |
| Princeton University | Princeton, NJ | 11 | $16.7 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 11 | $16.3 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 15 | $16.2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 25 | $15.9 million | 0 | $0 |
| Hektoen Institute for Medical Research | Chicago, IL | 1 | $15.7 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 21 | $15.4 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 10 | $15.3 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 18 | $14.8 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 14 | $14.7 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 13 | $14.5 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 11 | $14.5 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 18 | $14.3 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 7 | $14.1 million | 0 | $0 |
| Augusta University | Augusta, GA | 4 | $13.8 million | 0 | $0 |
| New York University | New York, NY | 9 | $12.8 million | 0 | $0 |
| Rockefeller University | New York, NY | 9 | $12.7 million | 0 | $0 |
| Brown University | Providence, RI | 13 | $12.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 14 | $12.6 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 8 | $12.4 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 11 | $12.2 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 16 | $11.7 million | 0 | $0 |
| University of Nebraska-Lincoln | Lincoln, NE | 6 | $11.5 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 7 | $11.4 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 13 | $11.2 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 6 | $11.1 million | 0 | $0 |
| Montana State University | Bozeman, MT | 7 | $10.6 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 10 | $10.4 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,604 | $1,315,802,811 | 0 | $0 |
| 2024 | 1,707 | $1,365,549,844 | 0 | $0 |
| 2023 | 1,656 | $1,646,368,947 | 0 | $0 |
| 2022 | 1,621 | $1,405,466,446 | 0 | $0 |
| 2021 | 1,532 | $1,371,367,761 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 30 awards here | |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | May 7, 2027 | Not listed | Notice number printed on 9 awards here | |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 5 awards here | |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | May 7, 2027 | Not listed | Notice number printed on 3 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 2 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) | PA-24-181 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | December 3, 2026 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 798 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 798 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 798 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 798 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 798 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 798 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.